Can supercharged immune cells stop leukemia from returning?
NCT ID NCT07237230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether infusing special immune cells called γδ T cells can prevent relapse in people with high-risk acute myeloid leukemia (AML) who have had a stem cell transplant. The trial will enroll 40 adults aged 18 to 65. The main goal is to see if the treatment improves relapse-free survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
γδ T cells (a type of immune cell)
What this could lead to
If it works, this could offer a new way to prevent leukemia from coming back after a stem cell transplant, potentially improving long-term survival.
What could go wrong
This is an early, small trial with only 40 participants. The treatment may not prevent relapse and could cause side effects like graft-versus-host disease or infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••